{
  "docId": "019de516-01ce-701d-bd9b-acac15fa9fab",
  "docSlug": "a13be9775a99db49a0c5c2ac3ee2ea88",
  "documentTitle": "Oculis | Investor Conference Presentation Deck | 39 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 39,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "kpi_overview",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-01ce-701d-bd9b-acac15fa9fab/4",
  "deckHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab",
  "deckJsonHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab.json",
  "deckAnchorHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.26,
        "w": 0.33,
        "x": 0.04,
        "y": 0.32
      },
      "kind": "image",
      "text": "Cyclodextrin Drug molecule Single complex Complex aggregate water-soluble nanoparticle",
      "attrs": {},
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "01952c11-af77-4e2b-ad75-934bb580fcc2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.26,
        "w": 0.29,
        "x": 0.37,
        "y": 0.32
      },
      "kind": "image",
      "text": "Regions that bind to neutralize TNFα IgG Fab scFv",
      "attrs": {},
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6d53f423-393f-4dac-b178-94f41e21d19b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.26,
        "w": 0.17,
        "x": 0.74,
        "y": 0.32
      },
      "kind": "image",
      "text": "To address neurological damage",
      "attrs": {},
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6e53caac-e27b-4cce-8118-4cac30f68cc9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.039,
        "w": 0.128,
        "x": 0.846,
        "y": 0.06
      },
      "kind": "image",
      "text": "Oculis",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e08b829-4e82-420b-8a52-4b46e86a7c35",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.26,
        "x": 0.07,
        "y": 0.63
      },
      "kind": "list",
      "text": "Phase 3 in DME and Ocular Surgery\nProprietary technology for front and back of the eye\nTopical Diabetic Macular Edema treatment candidate",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "36592960-38ec-4192-9b82-e6f6d18556fe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.26,
        "x": 0.69,
        "y": 0.18
      },
      "kind": "list",
      "text": "OCS-05\nPromising neuroprotective\nagent for neuro retina diseases",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "426b89b9-8682-461b-b841-9330648d776b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.26,
        "x": 0.07,
        "y": 0.18
      },
      "kind": "list",
      "text": "OCS-01\nOPTIREACH® enables eye drops\ntreating retinal disease",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5171e872-e20c-42a0-b86f-ca47a27eb223",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.26,
        "x": 0.69,
        "y": 0.63
      },
      "kind": "list",
      "text": "Phase 1/2a in Acute Optic Neuritis, with multiple additional applications\nSGK-2 activator with neuroprotective potential for Glaucoma, Geographic Atrophy, Diabetic Retinopathy & Neurotrophic Keratitis",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d216efc-c74d-47a3-8333-d592458d0b41",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.26,
        "x": 0.38,
        "y": 0.63
      },
      "kind": "list",
      "text": "Phase 2b in Dry Eye Disease and Uveitis\nTopical TNFα inhibitor for severe Dry Eye Disease with potential biomarker for precision medicines",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a2897c1-5cde-4701-a2ee-dbeeef7804e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.26,
        "x": 0.38,
        "y": 0.18
      },
      "kind": "list",
      "text": "OCS-02\nAntibody fragment technology\nenables biologic eye drop",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f26d5966-db7b-42a8-b02b-bd499bc59c47",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.01,
        "x": 0.95,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "4",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f3c1a8e2-4580-48b9-b836-cdf08289ef2c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.039,
        "w": 0.83,
        "x": 0.026,
        "y": 0.06
      },
      "kind": "title",
      "text": "3 Major Innovations Addressing Highly Meaningful Unmet Medical Needs",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6583e572-5b22-4a4e-9d38-def4e56f2a45",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 3,
      "beatId": "dd061c55-104a-4b61-98e2-4402947bffe6",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Situation & Context",
      "beatSlug": "consultants-gambit-situation-context",
      "evidence": "Slides 3-6 provide an overview of Oculis's purpose and pipeline.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "e5858f71-7892-4640-bcd5-6dc5fae5ed8f",
      "evidence": "Slides 3-6 provide an overview of Oculis's purpose and pipeline, framing the context for their solutions.",
      "position": 1,
      "objective": "Explain why Oculis's innovations matter",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}